Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring. [electronic resource]
Producer: 20090729Description: 1087-98 p. digitalISSN:- 1600-6143
- Alemtuzumab
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antibodies, Neoplasm -- therapeutic use
- Antigens, CD -- blood
- B-Lymphocytes -- drug effects
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Forkhead Transcription Factors -- analysis
- Graft Rejection -- prevention & control
- HLA Antigens -- blood
- Humans
- Hypersensitivity, Delayed -- drug therapy
- Immunosuppressive Agents -- therapeutic use
- Kidney Diseases -- classification
- Kidney Transplantation -- immunology
- Male
- Monitoring, Immunologic -- methods
- Sirolimus -- therapeutic use
- Tacrolimus -- therapeutic use
- White People
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.